Belpointe Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
ATO
RG
MF
BT
Belpointe Asset Management's BSX Position: Q2 2026 in Review
Belpointe Asset Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 25,588 shares — an estimated $1.61M sold.
Belpointe Asset Management first reported a position in BSX in Q2 2021 and held it in 16 quarters. The position peaked at $1.61M in Q1 2026. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Belpointe Asset Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Belpointe Asset Management sold 25,588 Boston Scientific shares in Q2 2026, an estimated $1.61M.
- Belpointe Asset Management first reported a position in Boston Scientific in Q2 2021 and held it in 16 quarters.
- Belpointe Asset Management's Boston Scientific position peaked at $1.61M in Q1 2026.
- 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.